Relationship between risk stratification by cardiac troponin level and adherence to guidelines for non-ST-segment elevation acute coronary syndromes

Archives of Internal Medicine

Volumn 165, Issue 16, 2005, Pages 1870-1876

  Roe, Matthew T ^a,k   Peterson, Eric D ^a   Li, Yun ^b   Pollack Jr , Charles V ^c   Christenson, Robert H ^d   Peacock, W Frank ^e   Fesmire, Francis M ^f   Newby, L Kristin ^a   Jesse, Robert L ^g   Hoekstra, James W ^h   Gibler, W Brian ⁱ   Ohman, E Magnus ^j  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c PENNSYLVANIA HOSPITAL   (United States)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^e LERNER RESEARCH INSTITUTE   (United States)

^f Erlanger Medical Center   (United States)

^g VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h WAKE FOREST SCHOOL OF MEDICINE   (United States)

ⁱ UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^j UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^k DUKE CLINICAL RESEARCH INSTITUTE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; TROPONIN;

ADULT; AGED; ARTICLE; CHRONIC KIDNEY FAILURE; COMPARATIVE STUDY; CONTROLLED STUDY; DECISION MAKING; FEMALE; HEART CATHETERIZATION; HEART MUSCLE ISCHEMIA; HUMAN; LABORATORY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK ASSESSMENT; ST SEGMENT ELEVATION;

ACUTE DISEASE; AGED; ANGINA, UNSTABLE; ELECTROCARDIOGRAPHY; FEMALE; GUIDELINE ADHERENCE; HEART CONDUCTION SYSTEM; HUMANS; MALE; MIDDLE AGED; PRACTICE GUIDELINES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TROPONIN T;

EID: 25144444749     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.165.16.1870     Document Type: Article

References (30)

1. Ohman EM, Armstrong PW, Christenson RH, et al. Cardiac troponin T levels for risk stratification in acute myocardial ischemia. N Engl J Med. 1996;335:1333-1341.
2. Antman EM, Tanasijevic MJ, Thompson B, et al. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med. 1996;335:1342-1349.
3. Jaffe AS, Ravkilde J, Roberts R, et al. It's time to change to a troponin standard. Circulation. 2000;102:1216-1220.
4. Lindahl B, Venge P, Wallentin L. Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease. Circulation. 1996;93:1651-1657.
5. Newby LK, Christenson RH, Ohman EM, et al. Value of serial troponin T measures for early and late risk stratification in patients with acute coronary syndromes. Circulation. 1998;98:1853-1859.
6. Heidenreich PA, Alloggiamento T, Melsop K, McDonald KM, Go AS, Hlatky MA. The prognostic value of troponin in patients with non-ST-elevation acute coronary syndromes: a meta-analysis. J Am Coll Cardiol. 2001;38:478-485.
7. Heeschen C, Hamm CW, Goldmann B, Deu A, Langenbrink L, White HD. Troponin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of tirofiban. Lancet. 1999;354:1757-1762.
8. Hamm CW, Heeschen C, Goldmann B, et al. Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels. N Engl J Med. 1999;340:1623-1629.
9. Newby LK, Ohman EM, Christenson RH, et al. Benefit of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes and troponin T-positive status: the PARAGON-B troponin T substudy. Circulation. 2001;103:2891-2896.
10. Morrow DA, Antman EM, Tanasijevic M, et al. Cardiac troponin I for stratification of early outcomes and the efficacy of enoxaparin in unstable angina: a TIMIIIB substudy. J Am Coll Cardiol. 2000;36:1812-1817.
11. Morrow DA, Cannon CP, Rifai N, et al; TACTICS-TIMI 18 Investigators. Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST-elevation myocardial infarction: results from a randomized trial. JAMA. 2001;286:2405-2412.
12. Okamatsu K, Takano M, Sakai S, et al. Elevated troponin T levels and lesion characteristics in non-ST-elevation acute coronary syndromes. Circulation. 2004;109:465-470.
13. Heeschen C, van den Brand MJ, Hamm CW, Simoons ML. Angiographic findings in patients with refractory unstable angina according to troponin T status. Circulation. 1999;100:1509-1514.
14. Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: executive summary and recommendations: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Unstable Angina). Circulation. 2000;102:1193-1209.
15. Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: executive summary and recommendations: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Unstable Angina) - Summary Article. J Am Coll Cardiol. 2002;40:1366-1374.
16. Antman EM. Troponin measurements in ischemic heart disease: more than just a black and white picture? J Am Coll Cardiol. 2001;38:987-990.
17. Alpert JS. Defining myocardial infarction: "will the real myocardial infarction please stand up?" Am Heart J. 2003;146:377-379.
18. Thygesen K, Alpert JS. Myocardial infarction redefined: a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. J Am Coll Cardiol. 2000;36:959-968.
19. Hoekstra JW, Pollack CV, Roe MT, et al. Improving the care of patients with non-ST-elevation acute coronary syndromes in the emergency department: the CRUSADE Initiative. Acad Emerg Med. 2002;9:1146-1155.
20. Roe MT, Peterson ED, Pollack CV Jr, et al. Influence of timing of troponin elevation on clinical outcomes and use of evidence-based therapies for patients with non-ST-segment elevation acute coronary syndromes. Ann Emerg Med. 2005;45:355-362.
21. Boersma E, Pieper KS, Steyerberg EW, et al; PURSUIT Investigators. Predictors of outcome in patients with acute coronary syndromes without persistent STsegment elevation: results from an international trial of 9461 patients. Circulation. 2000;101:2557-2567.
22. Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika. 1986;73:13-22.
23. Smith PL. Splines as a useful and convenient statistical tool. Am Stat. 1979;33:57-62.
24. Ottervanger JP, Armstrong P, Barnathan ES, et al; GUSTO IV-ACS Investigators. Long-term results after the glycoprotein IIb/IIIa inhibitor abciximab in unstable angina: one-year survival in the GUSTO IV-ACS (Global Use of Strategies to Open Occluded Coronary Arteries IV-Acute Coronary Syndromes) trial. Circulation. 2003;107:437-442.
25. Wong GC, Morrow DA, Murphy S, et al. Elevations in troponin T and I are associated with abnormal tissue level perfusion: a TACTICS-TIMI 18 substudy: Treat Angina with Aggrastat and Determine Cost of Therapy with an Invasive or Conservative Strategy-Thrombolysis in Myocardial Infarction. Circulation. 2002;106:202-207.
26. Lindahl B, Diderholm E, Lagerqvist B, Venge P, Wallentin L. Mechanisms behind the prognostic value of troponin T in unstable coronary artery disease: a FRISC II substudy. J Am Coll Cardiol. 2001;38:979-986.
27. Alexander JH, Sparapani RA, Mahaffey KW, et al. Association between minor elevations of creatine kinase-MB level and mortality in patients with acute coronary syndromes without ST-segment elevation. JAMA. 2000;283:347-353.
28. Kontos MC, Fritz LM, Anderson FP, Tatum JL, Ornato JP, Jesse RL. Impact of troponin standard on the prevalence of acute myocardial infarction. Am Heart J. 2003;146:446-452.
29. Mukherjee D, Fang J, Chetcuti S, Moscucci M, Kline-Rogers E, Eagle KA. Impact of combination evidence-based medical therapy on mortality in patients with acute coronary syndromes. Circulation. 2004;109:745-749.
30. Allen LA, O'Donnell CJ, Guigliano RP. Care concordant with guidelines predicts decreased long-term mortality in patients with unstable angina pectoris and non-ST-elevation myocardial infarction. Am J Cardiol. 2004;93:1218-1222.